Neurologic Manifestations Seen in Most Hospitalized With COVID-19
Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.
Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.
In patients with epilepsy, post-ictal headaches are associated with drug-resistant epilepsy, generalized seizures, and a family history of migraine.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application for Libervant® (diazepam; Aquestive Therapeutics) buccal film for the management of seizure clusters.
Among infants breastfed by mothers who are receiving drug therapy for epilepsy, antiepileptic drug (AED) concentrations in infant blood samples are substantially lower than those in maternal blood samples.
Researchers find qEG may provide adequate reassurance that an asymptomatic infant with a normal qEEG will not develop SWS.
Children with pediatric epilepsy who undergo surgery may experience long-term changes in verbal and nonverbal IQ.
Patients with sepsis, particularly younger patients and those with CKD, may be at an elevated risk for new-onset epilepsy.
Using artificial tools to collect and analyze conversations and comments about epilepsy posted online, researchers revealed that 7.8% of all posts by teenagers with epilepsy were related to suicide, compared with 3.2% of adult posts.
Poor seizure control, lack of breastfeeding education from a neurologist or lactation consultant, are factors contributing to lower breastfeeding rates in women with epilepsy, compared with the general population.
Investigators report cardiac arrhythmias with or without apnea among patients with epilepsy are associated with increased mortality risk.